BeStock  

Mesa Laboratories MLAB

US equityMarket cap rank #3480Scientific & Technical Instruments
$129.96 −$6.10 (-4.48%)
Pre-market · Oct 8, 8:10 am ET · After hours $130.00 +0.03%
Open$133.50
Prev close$136.06
Day range$129.73 – $135.35
Volume70.4K
Market cap$727.24M
P/E (TTM)152.9
Dividend yield0.49%

Earnings

Average move on report day±7.0%last 15 reports
Closed higher7 of 1547% of the time
Best reaction+11.0%
Worst reaction-24.9%

Stock move on the day after each report

-9.1%2023/Q3-2.0%2023/Q4+5.2%2024/Q1-1.4%2024/Q2+5.6%2024/Q3-13.3%2024/Q4+2.5%2025/Q3-24.9%2026/Q1+1.5%2026/Q2+8.7%2026/Q3-14.5%2026/Q4-1.0%2027/Q1
QuarterReport dateTimingImplied moveActual moveVersus implied
2027/Q110 Aug 2026None–-1.00%–
2026/Q427 May 2026Pre Market–-14.48%–
2026/Q33 Feb 2026Pre Market–+8.73%–
2026/Q26 Nov 2025After Market–+1.52%–
2026/Q15 Aug 2025Pre Market–-24.92%–
2025/Q34 Feb 2025Pre Market–+2.49%–
2024/Q431 May 2024Pre Market–-13.28%–
2024/Q35 Feb 2024Pre Market–+5.64%–
2024/Q26 Nov 2023Pre Market–-1.41%–
2024/Q13 Aug 2023Pre Market–+5.23%–
2023/Q425 May 2023Pre Market–-1.97%–
2023/Q36 Feb 2023Pre Market–-9.08%–
2019/Q34 Feb 2019Pre Market–+1.42%–
2018/Q35 Feb 2018After Market–-3.32%–
2016/Q42 Jun 2016None–+11.01%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2027/Q1

By business line

  • Sterilization and Disinfection Control$24.51M 40.7%
  • Calibration Solutions$13.29M 22.1%
  • Biopharmaceutical Development$12.06M 20.1%
  • Clinical Genomics$10.29M 17.1%

Latest reported quarter: Q1, ended Jun 2026

Revenue$60.14M+1.0% YoY
Operating profit$7.03M+129.5% YoY
Net profit$2.83M-40.3% YoY
Diluted EPS$0.49-42.4% YoY
Free cash flow$14.18M+1,503.7% YoY
Operating cash flow$14.74M

Revenue, last 8 quarters

$57.8MSep '24$62.8MDec '24$62.1MMar '25$59.5MJun '25$60.7MSep '25$65.1MDec '25$63.7MMar '26$60.1MJun '26

Net profit, last 8 quarters

$3.4MSep '24$-1.7MDec '24$-7.1MMar '25$4.7MJun '25$2.5MSep '25$3.6MDec '25$-4.1MMar '26$2.8MJun '26

Profitability & balance sheet

Gross margin64.2%
Operating margin9.0%
Net margin1.9%
Return on equity2.7%
Return on assets1.1%
Return on invested capital3.2%
Current ratio1.79
Liabilities / assets55.0%
Cash & investments$30.70M
Total debt$142.87M
Net cash (debt)-$112.17M
Free cash flow / sales21.2%

Discussion

No comments yet — be the first to weigh in on MLAB.

Leave a comment

Scroll to Top